Levetiracetam as Treatment for a Woman with Epilepsy in Pregnancy: A Case Report and Discussion

Karunakaran, K.E

dc.contributor.author	Karunakaran, K.E
dc.date.accessioned	2022-08-24T04:21:24Z
dc.date.available	2022-08-24T04:21:24Z
dc.date.issued	2021
dc.identifier.uri	http://dlfhcs.esn.ac.lk/handle/123456789/839
dc.description	Neurological Disorders and Stroke International	en_US
dc.description.abstract	Epilepsy in pregnancy raises concern for optimum seizure control with safety of the fetus from teratogenicity. Levetiracetam is a broad-spectrum Antiepileptic Drug (AED) and is reported to be safe. Our experience with this medication seems very limited. We herewith present a case from Teaching Hospital, Batticaloa, Sri Lanka. COVID-19 restrictions hampered the continuous compliance to treatment however, with good outcome.	en_US
dc.language.iso	en	en_US
dc.subject	Epilepsy in pregnancy	en_US
dc.subject	Levetiracetam	en_US
dc.subject	Compliance	en_US
dc.title	Levetiracetam as Treatment for a Woman with Epilepsy in Pregnancy: A Case Report and Discussion	en_US
dc.type	Article	en_US